1 (130) | Hypertension Arterielle, Pulmonaire: Physiopathologie et Innovation Therapeutique | FRA | ||
2 (144) | GlaxoSmithKline, United Kingdom | GBR | ||
3 (179) | Boehringer Ingelheim GmbH Germany | DEU | ||
4 (291) | AstraZeneca, Sweden | SWE | ||
5 (346) | AstraZeneca, United Kingdom | GBR | ||
6 (580) | Novartis, Switzerland | CHE | ||